Literature DB >> 19440711

The immunopathogenesis of alcoholic and nonalcoholic steatohepatitis: two triggers for one disease?

Luca Valenti1, Anna Ludovica Fracanzani, Silvia Fargion.   

Abstract

Alcoholic liver disease and nonalcoholic liver disease represent a leading cause of liver disease and share similar pathogenic mechanisms among which activation of the immune system plays a key role. The main events consist in (a) activation of Kupffer cells via TLR-4 by LPS and fatty acids (b) complement activation (c) increased release of proinflammatory mediators (d) alteration in NK and NKT cell number/activity (e) activation of the adaptive immune system. At the same time, activation of intracellular pro-inflammatory pathways by cytokines and bacterial products, inhibit insulin signaling favoring lipogenesis, metabolic alterations, and cell damage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19440711     DOI: 10.1007/s00281-009-0152-9

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  110 in total

1.  Association of the frequency of peripheral natural killer T cells with nonalcoholic fatty liver disease.

Authors:  Cheng-Fu Xu; Chao-Hui Yu; You-Ming Li; Lei Xu; Juan Du; Zhe Shen
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

2.  Adiponectin normalizes LPS-stimulated TNF-alpha production by rat Kupffer cells after chronic ethanol feeding.

Authors:  Varsha Thakur; Michele T Pritchard; Megan R McMullen; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-01-12       Impact factor: 4.052

3.  Screening of 134 single nucleotide polymorphisms (SNPs) previously associated with type 2 diabetes replicates association with 12 SNPs in nine genes.

Authors:  Cristen J Willer; Lori L Bonnycastle; Karen N Conneely; William L Duren; Anne U Jackson; Laura J Scott; Narisu Narisu; Peter S Chines; Andrew Skol; Heather M Stringham; John Petrie; Michael R Erdos; Amy J Swift; Sareena T Enloe; Andrew G Sprau; Eboni Smith; Maurine Tong; Kimberly F Doheny; Elizabeth W Pugh; Richard M Watanabe; Thomas A Buchanan; Timo T Valle; Richard N Bergman; Jaakko Tuomilehto; Karen L Mohlke; Francis S Collins; Michael Boehnke
Journal:  Diabetes       Date:  2007-01       Impact factor: 9.461

4.  Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease.

Authors:  Zhiping Li; Mark J Soloski; Anna Mae Diehl
Journal:  Hepatology       Date:  2005-10       Impact factor: 17.425

5.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial.

Authors:  E Akriviadis; R Botla; W Briggs; S Han; T Reynolds; O Shakil
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

6.  Regulation of human monocyte functions by acute ethanol treatment: decreased tumor necrosis factor-alpha, interleukin-1 beta and elevated interleukin-10, and transforming growth factor-beta production.

Authors:  G Szabo; P Mandrekar; L Girouard; D Catalano
Journal:  Alcohol Clin Exp Res       Date:  1996-08       Impact factor: 3.455

7.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

8.  Portal lymphocytic infiltrate in alcoholic liver disease.

Authors:  Magali Colombat; Frédéric Charlotte; Vlad Ratziu; Thierry Poynard
Journal:  Hum Pathol       Date:  2002-12       Impact factor: 3.466

9.  Free fatty acid-induced hepatic insulin resistance: a potential role for protein kinase C-delta.

Authors:  Tony K T Lam; Hidenori Yoshii; C Andrew Haber; Elena Bogdanovic; Loretta Lam; I George Fantus; Adria Giacca
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-10       Impact factor: 4.310

Review 10.  Neutrophilic infiltration in alcoholic hepatitis.

Authors:  Abraham P Bautista
Journal:  Alcohol       Date:  2002-05       Impact factor: 2.405

View more
  25 in total

1.  High-fat-induced intestinal permeability dysfunction associated with altered fecal bile acids.

Authors:  Lotta K Stenman; Reetta Holma; Riitta Korpela
Journal:  World J Gastroenterol       Date:  2012-03-07       Impact factor: 5.742

2.  Steroid-Mediated Decrease in Blood Mesenchymal Stem Cells in Liver Transplant could Impact Long-Term Recovery.

Authors:  Nykia D Walker; Yasmine Mourad; Katherine Liu; Michael Buxhoeveden; Catherine Schoenberg; Jean D Eloy; Dorian J Wilson; Lloyd G Brown; Andrei Botea; Faraz Chaudhry; Steven J Greco; Nicholas M Ponzio; Nikolaos Pyrsopoulos; Baburao Koneru; Yuriy Gubenko; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2017-10       Impact factor: 5.739

Review 3.  The effect of bariatric surgeries on nonalcoholic fatty liver disease.

Authors:  Mazen Hassanian; Amnah Al-Mulhim; Atheer Al-Sabhan; Shaden Al-Amro; Fahad Bamehriz; Ayman Abdo; Hisham Al Khalidi; Tamader A Aldoheyan
Journal:  Saudi J Gastroenterol       Date:  2014 Sep-Oct       Impact factor: 2.485

Review 4.  Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors.

Authors:  Paola Dongiovanni; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

5.  Single-nucleotide rs738409 polymorphisms in the PNPLA3 gene are strongly associated with alcoholic liver disease in Han Chinese males.

Authors:  Yanfang Zhang; Tongsheng Guo; Funing Yang; Yuanli Mao; Liubing Li; Chenxi Liu; Qiang Sun; Yongzhe Li; Jing Huang
Journal:  Hepatol Int       Date:  2018-08-21       Impact factor: 6.047

6.  Differential Activation of Hepatic Invariant NKT Cell Subsets Plays a Key Role in Progression of Nonalcoholic Steatohepatitis.

Authors:  Igor Maricic; Idania Marrero; Akiko Eguchi; Ryota Nakamura; Casey D Johnson; Suryasarathi Dasgupta; Carolyn D Hernandez; Phirum Sam Nguyen; Austin D Swafford; Rob Knight; Ariel E Feldstein; Rohit Loomba; Vipin Kumar
Journal:  J Immunol       Date:  2018-10-15       Impact factor: 5.422

Review 7.  Pathology of nonalcoholic fatty liver disease.

Authors:  Elizabeth M Brunt
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-03-02       Impact factor: 46.802

Review 8.  Role of innate immunity in the development of hepatocellular carcinoma.

Authors:  Rajagopal N Aravalli
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

9.  Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats.

Authors:  Wei Zhang; Lu-Wen Wang; Li-Kun Wang; Xun Li; Hong Zhang; Li-Ping Luo; Jin-Chun Song; Zuo-Jiong Gong
Journal:  Dig Dis Sci       Date:  2013-07-17       Impact factor: 3.199

Review 10.  PNPLA3 I148M polymorphism and progressive liver disease.

Authors:  Paola Dongiovanni; Benedetta Donati; Roberta Fares; Rosa Lombardi; Rosellina Margherita Mancina; Stefano Romeo; Luca Valenti
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.